PLOS ONE: Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
![Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results](https://www.natap.org/2016/images/072916/072916-3/IAC1.gif)
Raltegravir (RAL) 1200 mg Once Daily (QD) is Non-Inferior to RAL 400 mg Twice Daily (BID), in Combination with Tenofovir/Emtricitabine, in Treatment-Naïve HIV-1 Infected Subjects: Week 48 Results
![Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study - Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study -](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2012320312/2034333992/gr1.jpg)
Safety and Efficacy of 8-mg Once-daily vs 4-mg Twice-daily Silodosin in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (SILVER Study): A 12-Week, Double-blind, Randomized, Parallel, Multicenter Study -
![Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d87e56a5-1c6e-4385-aba8-b21849591cca/gr1.jpg)
Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): a meta-analysis of randomized clinical trials - Radiotherapy and Oncology
![Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/dff88bc4-9a2c-4486-a0e7-512cca1f1a71/gr1.jpg)
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice
![What does bd/bid mean? - Definition of bd/bid - bd/bid stands for Twice a day. By AcronymsAndSlang.com What does bd/bid mean? - Definition of bd/bid - bd/bid stands for Twice a day. By AcronymsAndSlang.com](http://acronymsandslang.com/acronym_image/2595/7c9dfdd33f35cb4e59e4149254e78740.jpg)
What does bd/bid mean? - Definition of bd/bid - bd/bid stands for Twice a day. By AcronymsAndSlang.com
![Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download](https://images.slideplayer.com/24/7554031/slides/slide_7.jpg)
Medical Terminology How much do you know?. 24 Hour Clock Write out the times 10:40 pm 6:35 am 4:49 pm 12:50 pm 11:05 am If you have a basketball game. - ppt download
![Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML](https://www.mdpi.com/cancers/cancers-14-01330/article_deploy/html/images/cancers-14-01330-g001.png)
Cancers | Free Full-Text | Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center | HTML
![Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - Diabetes Research and Clinical Practice Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - Diabetes Research and Clinical Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2053791383/2060350355/gr1.jpg)
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - Diabetes Research and Clinical Practice
![PDF] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism | Semantic Scholar PDF] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dde540c44fa469628bf8191911633538521d8117/9-Table4-1.png)
PDF] Impact of Once-Daily Versus Twice-Daily Dosing Frequency on Adherence to Chronic Medications among Patients with Venous Thromboembolism | Semantic Scholar
PLOS ONE: Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach
Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021
![Abbreviations: BID = twice daily; d = days; IV = intravenous; QID = 4... | Download Scientific Diagram Abbreviations: BID = twice daily; d = days; IV = intravenous; QID = 4... | Download Scientific Diagram](https://www.researchgate.net/profile/Myron-Genel/publication/309744625/figure/fig2/AS:624439670616068@1525889427306/Abbreviations-BID-twice-daily-d-days-IV-intravenous-QID-4-times-per-day-SCFN.png)